Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel class of monoamine transporter inhibitors

Bioorg Med Chem Lett. 2001 May 7;11(9):1113-8. doi: 10.1016/s0960-894x(01)00132-9.

Abstract

3,4-Disubstituted pyrrolidines were discovered as a novel class of monoamine transporter inhibitors through 3-D database pharmacophore searching using a new pharmacophore model. The most potent analogue 12 has Ki values of 0.084 microM in [3H]mazindol binding, 0.20, 0.23, and 0.031 microM in inhibition of dopamine (DA), serotonin (SER), and norepinephrine (NE) reuptake, respectively. Functional antagonism testing in vitro showed that 11 and 12 are weak cocaine antagonists.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Biogenic Monoamines / metabolism*
  • Carrier Proteins / antagonists & inhibitors*
  • Cocaine / antagonists & inhibitors
  • Dopamine Uptake Inhibitors / antagonists & inhibitors
  • Dopamine Uptake Inhibitors / metabolism
  • Mazindol / metabolism
  • Neurotransmitter Uptake Inhibitors / chemical synthesis
  • Neurotransmitter Uptake Inhibitors / pharmacology
  • Pyrrolidines / chemical synthesis*
  • Pyrrolidines / pharmacology
  • Quantitative Structure-Activity Relationship

Substances

  • Biogenic Monoamines
  • Carrier Proteins
  • Dopamine Uptake Inhibitors
  • Neurotransmitter Uptake Inhibitors
  • Pyrrolidines
  • Mazindol
  • Cocaine